[PHARMA] QoQ Quarter Result on 31-Dec-2017 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
27-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
QoQ- 506.15%
YoY- 2695.69%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 587,660 582,729 617,923 613,196 574,503 517,967 618,294 -3.32%
PBT 17,603 11,970 28,707 19,866 15,271 10,150 27,777 -26.20%
Tax -2,298 -6,204 -11,118 2,222 -11,381 -399 -8,519 -58.21%
NP 15,305 5,766 17,589 22,088 3,890 9,751 19,258 -14.18%
-
NP to SH 15,051 5,394 17,586 21,700 3,580 9,520 18,923 -14.14%
-
Tax Rate 13.05% 51.83% 38.73% -11.18% 74.53% 3.93% 30.67% -
Total Cost 572,355 576,963 600,334 591,108 570,613 508,216 599,036 -2.98%
-
Net Worth 522,618 519,642 524,838 526,888 531,892 542,147 544,360 -2.67%
Dividend
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Div 13,000 10,392 12,991 15,573 12,973 10,376 10,368 16.26%
Div Payout % 86.38% 192.67% 73.87% 71.77% 362.37% 108.99% 54.79% -
Equity
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Net Worth 522,618 519,642 524,838 526,888 531,892 542,147 544,360 -2.67%
NOSH 260,505 259,821 259,821 259,821 259,821 259,400 259,219 0.33%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 2.60% 0.99% 2.85% 3.60% 0.68% 1.88% 3.11% -
ROE 2.88% 1.04% 3.35% 4.12% 0.67% 1.76% 3.48% -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
RPS 226.02 224.28 237.83 236.25 221.42 199.68 238.52 -3.52%
EPS 5.79 2.08 6.77 8.36 1.38 3.67 7.30 -14.30%
DPS 5.00 4.00 5.00 6.00 5.00 4.00 4.00 16.02%
NAPS 2.01 2.00 2.02 2.03 2.05 2.09 2.10 -2.87%
Adjusted Per Share Value based on latest NOSH - 259,821
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
RPS 40.77 40.43 42.87 42.55 39.86 35.94 42.90 -3.33%
EPS 1.04 0.37 1.22 1.51 0.25 0.66 1.31 -14.24%
DPS 0.90 0.72 0.90 1.08 0.90 0.72 0.72 16.02%
NAPS 0.3626 0.3605 0.3642 0.3656 0.369 0.3762 0.3777 -2.68%
Price Multiplier on Financial Quarter End Date
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Date 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 -
Price 2.89 2.88 4.28 4.60 4.14 4.58 4.89 -
P/RPS 1.28 1.28 1.80 1.95 1.87 2.29 2.05 -26.92%
P/EPS 49.93 138.73 63.23 55.02 300.05 124.80 66.99 -17.77%
EY 2.00 0.72 1.58 1.82 0.33 0.80 1.49 21.66%
DY 1.73 1.39 1.17 1.30 1.21 0.87 0.82 64.42%
P/NAPS 1.44 1.44 2.12 2.27 2.02 2.19 2.33 -27.42%
Price Multiplier on Announcement Date
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Date 19/11/18 17/08/18 16/05/18 27/02/18 15/11/17 16/08/17 16/05/17 -
Price 3.09 3.11 4.07 4.04 3.82 4.19 4.72 -
P/RPS 1.37 1.39 1.71 1.71 1.73 2.10 1.98 -21.75%
P/EPS 53.38 149.80 60.13 48.32 276.85 114.17 64.66 -11.98%
EY 1.87 0.67 1.66 2.07 0.36 0.88 1.55 13.31%
DY 1.62 1.29 1.23 1.49 1.31 0.95 0.85 53.65%
P/NAPS 1.54 1.56 2.01 1.99 1.86 2.00 2.25 -22.31%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment